There are 807 resources available
Checkpoint inhibition beyond anti-PD(L)1 and anti-CTLA4: What progress?
Presenter: Han Chong Toh
Session: Cancer immunotherapy in 2022
Resources:
Slides
Webcast
Latest advances in the surgical approach of primary and advanced GIST
Presenter: Yvonne Schrage
Session: Latest advances in the treatment of gastrointestinal stromal tumour (GIST)
Resources:
Slides
Webcast
Invited Discussant 43O
Presenter: Iain Tan
Session: Proffered Paper and Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
182MO - Immune co-regulator (co-reg) expression in mismatch repair-deficient (MMRd) endometrial cancer (EC) patients (pts): Anti-PD-(L)1-responders (R) versus (vs) non-responders (NR)
Presenter: Juan Francisco Grau Béjar
Session: Mini Oral session: Gynaecological tumours
Resources:
Abstract
Slides
Webcast
Use of immunomodulators in the treatment of haematological malignancies
Presenter: Michelle Poon
Session: Developing immunotherapies in haematolgical malignancies
Resources:
Slides
Webcast
Medical oncologist perspectives
Presenter: Muh-Hwa Yang
Session: Potential benefits and limitations of IO in localised head and neck cancer
Resources:
Slides
Webcast
Cellular therapy: Finally prime time in solid tumours?
Presenter: Inge-Marie Svane
Session: Cancer immunotherapy in 2022
Resources:
Slides
Webcast
Latest advances in the systemic approach to primary and advanced GIST
Presenter: Tom Wei-Wu Chen
Session: Latest advances in the treatment of gastrointestinal stromal tumour (GIST)
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Jeanne Tie
Session: Proffered Paper and Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
183MO - Retreatment with platinum-based chemotherapy for recurrent endometrial cancer: The concept of platinum sensitivity in endometrial cancer
Presenter: Joseph Noh
Session: Mini Oral session: Gynaecological tumours
Resources:
Abstract
Slides
Webcast